Explore the latest in hidradenitis suppurativa, including advances in understanding the pathophysiology and treatment of the disorder.
This case-control study investigates the mesenchymal stem cell profile in patients with hidradenitis suppurativa and in healthy controls, with punch biopsy samples from axillary skin analyzed for immunophenotypic profiles.
This cohort analysis evaluates the association of low socioeconomic status with hidradenitis suppurativa among patients in the United States.
A woman in her 50s with a medical history of hypertension and depression was evaluated by the inpatient dermatology consult service for a 1.5-year history of painful intertriginous wounds; she was previously diagnosed with hidradenitis suppurativa. What is your diagnosis?
This case series uses semantic map analysis to assess the association of hidradenitis suppurativa with T helper 1/T helper 17 phenotypes.
This case-control study investigates whether body image is impaired in patients with hidradenitis suppurativa and whether disease severity, age at onset, disease duration, obesity, depression, and anxiety are linked to body image impairment.
This study examines the accuracy and clinical relevance of a newly developed scoring system for hidradenitis suppurativa severity.
This survey study uses clinical data from a set of self-administered, self-graded questionnaires to examine the correlation among resilience, depression, and health-related quality of life for patients with hidradenitis suppurativa.
This narrative review summarizes the diagnosis, epidemiology, and treatment of hidradenitis suppurativa, with an emphasis on advances in the last 5 years.
This case report describes the use of canakinumab to treat 2 patients with severe hidradenitis suppurativa.
This case-control study investigates the follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls.
This population-based analysis establishes standardized overall and sex- and age-specific prevalence estimates for hidradenitis suppurativa in the United States.
This Clinical Evidence Synopsis summarizes a Cochrane review assessing which treatments have been shown to be effective in randomized clinical trials for hidradenitis suppurativa in adults.
This study examines the prevalence of Firmicutes in bacterial cultures of purulent drainage from hidradenitis suppurativa lesions and explores its potential association with body mass index.
This qualitative study examines coping styles of patients diagnosed with hidradenitis suppurativa.
This retrospective cohort analysis identifies clinical and demographic factors that patients and clinicians may consider in developing partnered short- and long-term treatment strategies for hidradenitis suppurativa.
This cohort study uses Danish National Registry data to compare the risk of cardiovascular events among patients with hidradenitis suppurativa, severe psoriasis, and healthy individuals.
This randomized clinical trial investigated the safety and efficacy of the anti-inflammatory biological therapy anakinra in 20 patients with Hurley stage II or III hidradenitis suppurativa.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: